ARTICLE | Financial News
Raven raises $40 million
January 3, 2003 8:00 AM UTC
Cancer antibody developer Raven Biotechnologies (South San Francisco, Calif.) raised $40 million in a series C round led by Bear Stearns Health Innoventures. Other investors included Pequot Ventures; ...